01:43 PM EDT, 03/18/2024 (MT Newswires) -- Clearside Biomedical ( CLSD ) said Monday it appointed Victor Chong as chief medical officer.

The company said Chong previously served as vice president and global head of Retina DAS at Johnson & Johnson's ( JNJ ) Innovative Medicine unit, formerly Janssen.

Clearside shares were down 4.1% in recent trading.

Price: 1.64, Change: -0.07, Percent Change: -4.09